These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
☐ Large accelerated filer
|
☐ Accelerated filer
|
|
|
☒
|
|
|
|
|
|
3
|
||
|
Item 1. Interim Financial Statements
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
7
|
||
| 21 |
||
| 25 |
||
| 25 |
||
| 26 |
||
| 26 |
||
| 26 |
||
| 26 |
||
| 26 |
||
| 26 |
||
| 27 |
||
| 28 |
||
|
March 31,
2022
|
December 31,
2021
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Cash
|
$
|
|
$
|
|
||||
|
Prepaid expenses
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Marketable securities held in Trust Account
|
|
|
||||||
|
Total Assets
|
$
|
|
$
|
|
||||
|
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
|
$
|
|
||||
|
Due to related party
|
|
|
||||||
|
Accrued expenses
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Deferred underwriting fees payable
|
|
|
||||||
|
Derivative warrant liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and Contingencies (Note 5)
|
||||||||
|
Class A ordinary shares subject to possible redemption,
|
|
|
||||||
|
Shareholders’ deficit
|
||||||||
|
Preference shares, $
|
|
|
||||||
|
Class A ordinary shares, $
|
|
|
||||||
|
Class B ordinary shares, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ deficit
|
(
|
)
|
(
|
)
|
||||
|
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
|
$
|
|
$
|
|
||||
|
For The Three
Months Ended
March 31, 2022
(Unaudited)
|
||||
|
Formation and operating costs
|
|
|||
|
Loss from operations
|
(
|
)
|
||
|
Change in fair value of derivative warrant liabilities
|
|
|||
|
Gain on marketable securities (net), dividends and interest, held in Trust Account
|
|
|||
|
Compensation expense
|
(
|
)
|
||
|
Net income
|
$
|
|
||
|
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted
|
|
|||
|
Basic and diluted per share, Class A subject to possible redemption
|
$
|
|
||
|
Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted
|
|
|||
|
Basic and diluted per share, Class B non-redeemable ordinary shares
|
$
|
|
||
|
Ordinary Shares Subject
to Possible Redemption
|
Ordinary Shares
|
|||||||||||||||||||||||||||
|
Class A
|
Class B
|
|||||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-In
Capital
|
Accumulated
Deficit
|
Total
Shareholders’
Deficit
|
||||||||||||||||||||||
|
Balance as of January 1, 2022
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
|
Share based compensation to Directors
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
|
Net income
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
|
Balance as of March 31, 2022 (unaudited)
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
|
For The Three Months Ended March 31, 2022 (Unaudited)
|
||||
|
Cash Flows from Operating Activities
|
||||
|
Net income
|
$
|
|
||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||
|
Compensation expense
|
|
|||
|
Gain on marketable securities (net), dividends and interest, held in Trust Account
|
(
|
)
|
||
|
Formation and operating expenses funded by note payable through Sponsor
|
|
|||
|
Change in fair value of derivative warrant liabilities
|
(
|
)
|
||
|
Changes in operating assets and liabilities:
|
||||
|
Prepaid and other assets
|
|
|||
|
Accounts payable
|
(
|
)
|
||
|
Accrued expenses
|
|
|||
|
Net cash used in operating activities
|
(
|
)
|
||
|
Cash Flows from Financing Activities
|
||||
|
Repayment of note payable and advances from related party
|
(
|
)
|
||
|
Offering costs paid
|
(
|
)
|
||
|
Net cash provided by financing activities
|
(
|
)
|
||
|
Net decrease in cash
|
(
|
)
|
||
|
Cash - beginning of period
|
|
|||
|
Cash - end of period
|
$
|
|
||
|
Supplemental disclosure of noncash investing and financing activities:
|
||||
|
Offering costs included in accounts payable
|
$
|
|
||
|
Offering costs included in accrued expenses at 12/31/2021
|
$
|
(
|
)
|
|
|
Offering costs paid through promissory note - related party
|
$
|
(
|
)
|
|
|
•
|
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
|
|
•
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for
identical or similar instruments in markets that are not active; and
|
|
•
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which
one or more significant inputs or significant value drivers are unobservable.
|
|
For The Three
Months Ended
March 31, 2022
(Unaudited)
|
||||
|
Redeemable Class A Ordinary Shares
|
||||
|
Numerator: Net income allocable to Redeemable Class A Ordinary Shares
|
$
|
|
||
|
Denominator: Weighted Average Share Outstanding, Redeemable Class A Ordinary Shares
|
||||
|
Basic and diluted weighted average shares outstanding, Redeemable Class A
|
|
|||
|
Basic and diluted per share, Class A subject to possible redemption
|
$
|
|
||
|
Non-Redeemable Class B Ordinary Shares
|
||||
|
Numerator: Net income allocable to non-redeemable Class B Ordinary Shares
|
||||
|
Net income allocable to non-redeemable Class B Ordinary Shares
|
$
|
|
||
|
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares
|
|
|||
|
Basic and diluted per share, Class B non-redeemable ordinary shares
|
$
|
|
||
|
•
|
in whole and not in part;
|
|
•
|
at a price of $
|
|
•
|
upon a minimum of
|
|
•
|
if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $
|
|
•
|
in whole and not in part;
|
|
•
|
at a price of $
|
|
•
|
if, and only if, the closing price of Class A ordinary shares equals or exceeds $
|
|
•
|
if the closing price of the Class A ordinary shares for any
|
|
Level 1
|
Level 2 | Level 3 | Total | |||||||||||||
|
Assets
|
||||||||||||||||
|
Marketable securities held in Trust Account
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
|
Liabilities:
|
||||||||||||||||
|
Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Private Placement Warrants
|
|
|
|
|
||||||||||||
|
Total liabilities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Marketable securities held in Trust Account
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
|
Liabilities:
|
||||||||||||||||
|
Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Private Placement Warrants
|
|
|
|
|
||||||||||||
|
Total liabilities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
As of December 31, 2021
|
||||
|
Volatility
|
|
%
|
||
|
Underlying stock price
|
$
|
|
||
|
Expected time until merger (years)
|
|
|||
|
Risk-free rate
|
|
%
|
||
|
Dividend yield
|
|
%
|
||
|
Public
Warrants |
Private
Warrants
|
Total
|
||||||||||
|
Fair value at January 1, 2022
|
$
|
|
$
|
|
$
|
|
||||||
|
Change in fair value
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Fair value as of March 31, 2022
|
$
|
|
$
|
|
$
|
|
||||||
|
Public
Warrant |
Private
Warrant
|
Total
|
||||||||||
|
Change in fair value
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Fair value as of December 31, 2021
|
$
|
|
$
|
|
$
|
|
||||||
| ITEM 2. |
Management’s Discussion and Analysis for Financial Condition and Results of Operations
|
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 4. |
Controls and Procedures
|
| Item 1. |
Legal Proceedings.
|
| Item 1A. |
Risk Factors.
|
| Item 3. |
Defaults Upon Senior Securities.
|
| Item 4. |
Mine Safety Disclosures.
|
| Item 5. |
Other Information.
|
| Item 6. |
Exhibits
|
|
Exhibit
Number
|
Description
|
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Company’s Principal Executive and Principal Financial Officer.
|
||
|
Section 1350 Certification of the Company’s Principal Executive and Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and
Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
|
||
|
101.INS**
|
XBRL Instance Document
|
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB**
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
|
|
BULLPEN PARLAY ACQUISITION COMPANY
|
||
|
By:
|
/s/ David VanEgmond
|
|
|
David VanEgmond
|
||
|
Chief Executive Officer and Director
|
||
|
Date:
|
May 13, 2022
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|